TCM
LXRX icon

Tang Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Tang Capital Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-399,700
Closed -$624K – 53
2026
Q1 		$624K Buy
+399,700
New +$581K 0.03% 50
2025
Q2 		– Sell
-1,150,268
Closed -$530K – 210
2025
Q1 		$530K Buy
1,150,268
+300,000
+35% +$189K 0.03% 181
2024
Q4 		$628K Buy
850,268
+750,268
+750% +$904K 0.04% 169
2024
Q3 		$157K Buy
+100,000
New +$178K 0.01% 151

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Tang Capital Management's LXRX Position: Q2 2026 in Review

Tang Capital Management sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2026, closing a stake of 399,700 shares — an estimated $624K sold.

Tang Capital Management first reported a position in LXRX in Q3 2024 and held it in 4 quarters. The position peaked at $628K in Q4 2024. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Tang Capital Management reported no remaining Lexicon Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Tang Capital Management sold 399,700 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $624K.
  • Tang Capital Management first reported a position in Lexicon Pharmaceuticals in Q3 2024 and held it in 4 quarters.
  • Tang Capital Management's Lexicon Pharmaceuticals position peaked at $628K in Q4 2024.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Tang Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.